MNA
Manning & Napier Advisors’s AstraZeneca AZN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $150M | Sell |
2,152,535
-902,693
| -30% | -$63.1M | 1.79% | 15 |
|
2025
Q1 | $225M | Sell |
3,055,228
-690,303
| -18% | -$50.7M | 2.77% | 6 |
|
2024
Q4 | $245M | Buy |
3,745,531
+564,297
| +18% | +$37M | 2.8% | 6 |
|
2024
Q3 | $248M | Buy |
3,181,234
+764,562
| +32% | +$59.6M | 2.73% | 6 |
|
2024
Q2 | $188M | Buy |
+2,416,672
| New | +$188M | 2.13% | 10 |
|
2017
Q1 | – | Sell |
-495,960
| Closed | -$13.5M | – | 330 |
|
2016
Q4 | $13.5M | Hold |
495,960
| – | – | 0.09% | 103 |
|
2016
Q3 | $16.3M | Buy |
495,960
+8,190
| +2% | +$269K | 0.1% | 79 |
|
2016
Q2 | $14.7M | Hold |
487,770
| – | – | 0.09% | 87 |
|
2016
Q1 | $13.7M | Buy |
487,770
+27,930
| +6% | +$786K | 0.08% | 96 |
|
2015
Q4 | $15.6M | Buy |
459,840
+4,100
| +0.9% | +$139K | 0.09% | 95 |
|
2015
Q3 | $14.5M | Buy |
455,740
+227,870
| +100% | +$7.25M | 0.08% | 119 |
|
2015
Q2 | $14.5M | Hold |
227,870
| – | – | 0.06% | 126 |
|
2015
Q1 | $15.6M | Hold |
227,870
| – | – | 0.07% | 131 |
|
2014
Q4 | $16M | Sell |
227,870
-89,310
| -28% | -$6.29M | 0.07% | 130 |
|
2014
Q3 | $22.7M | Buy |
317,180
+8,150
| +3% | +$582K | 0.09% | 115 |
|
2014
Q2 | $23M | Sell |
309,030
-150,539
| -33% | -$11.2M | 0.09% | 117 |
|
2014
Q1 | $29.8M | Sell |
459,569
-31,309
| -6% | -$2.03M | 0.12% | 100 |
|
2013
Q4 | $29.1M | Sell |
490,878
-18,067
| -4% | -$1.07M | 0.13% | 93 |
|
2013
Q3 | $26.4M | Sell |
508,945
-2,722
| -0.5% | -$141K | 0.12% | 92 |
|
2013
Q2 | $24.2M | Buy |
+511,667
| New | +$24.2M | 0.13% | 91 |
|